These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27693386)

  • 1. Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
    Bashford-Rogers RJ; Palser AL; Hodkinson C; Baxter J; Follows GA; Vassiliou GS; Kellam P
    Exp Hematol; 2017 Feb; 46():31-37.e10. PubMed ID: 27693386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in chronic lymphocytic leukaemia associated with expression of CD5, a negative regulator of B-cell receptor signalling.
    Friedman DR; Guadalupe E; Volkheimer A; Moore JO; Weinberg JB
    Br J Haematol; 2018 Dec; 183(5):747-754. PubMed ID: 30407619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CXCR3 on Leukemic Cells Distinguishes
    Manukyan G; Papajik T; Mikulkova Z; Urbanova R; Kraiczova VS; Savara J; Kudelka M; Turcsanyi P; Kriegova E
    J Immunol Res; 2020; 2020():7084268. PubMed ID: 32802894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
    Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
    Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
    Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
    Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach.
    Colombo M; Bagnara D; Reverberi D; Matis S; Cardillo M; Massara R; Mastracci L; Ravetti JL; Agnelli L; Neri A; Mazzocco M; Squillario M; Mazzarello AN; Cutrona G; Agathangelidis A; Stamatopoulos K; Ferrarini M; Fais F
    Mol Med; 2020 Mar; 26(1):25. PubMed ID: 32156260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
    Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA
    Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.
    Gary-Gouy H; Sainz-Perez A; Marteau JB; Marfaing-Koka A; Delic J; Merle-Beral H; Galanaud P; Dalloul A
    J Immunol; 2007 Oct; 179(7):4335-44. PubMed ID: 17878328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
    Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
    Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.
    Wang C; Amato D; Rabah R; Zheng J; Fernandes B
    Leuk Res; 2002 Dec; 26(12):1125-9. PubMed ID: 12443886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
    Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
    Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.